Instrument Inactif

Communiqués Arca Biopharma Inc Nasdaq

Actions

US00211Y2090

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Shareholder Alert: Ademi LLP investigates Disclosure Issues involving ARCA biopharma, Inc.'s Transaction with Oruka	05/06	PR
ARCA BIOPHARMA INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of ARCA biopharma, Inc. - ABIO	11/05	BU
ARCA biopharma Announces First Quarter 2024 Financial Results and Provides Corporate Update	25/04	AQ
SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Announces an Investigation of ARCA Biopharma, Inc. - ABIO	10/04	PR
ARCA BIOPHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of ARCA biopharma, Inc. - ABIO	05/04	BU
Shareholder Alert: Ademi LLP investigates whether ARCA biopharma, Inc. has obtained a Fair Price in its transaction with Oruka	03/04	PR
ABIO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of ARCA Biopharma, Inc. Is Fair to Shareholders	03/04	BU
ARCA biopharma and Oruka Therapeutics Announce Merger Agreement	03/04	AQ
ARCA biopharma Announces 2023 Financial Results	01/02	AQ
ARCA biopharma Announces Third Quarter 2023 Financial Results	18/10/23	AQ
ARCA biopharma announces Second Quarter 2023 Financial Results	24/07/23	AQ
ARCA biopharma Announces Second Quarter 2023 Financial Results	21/07/23	AQ
ARCA biopharma : Company is currently engaged in a strategic review process, evaluating additional development of its assets, collaborations and other strategic options - Form 8-K	24/04/23	PU
ARCA BIOPHARMA, INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)	24/04/23	AQ
ARCA biopharma Announces First Quarter 2023 Financial Results	24/04/23	AQ
ARCA BIOPHARMA, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	24/04/23	AQ
ARCA biopharma Announces 2022 Financial Results and Provides Corporate Update	27/02/23	AQ
ARCA biopharma : Company is currently engaged in a strategic review process, evaluating additional development of its assets, collaborations and other strategic options - Form 8-K	24/02/23	PU
ARCA BIOPHARMA, INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)	24/02/23	AQ
ARCA BIOPHARMA, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	24/02/23	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Arca Biopharma Inc Nasdaq

Actions

US00211Y2090

Communiqués

Filtres